Guanxinkang Decoction Exerts Its Antiatherosclerotic Effect Partly through Inhibiting the Endoplasmic Reticulum Stress

Table 2

MMP of HUVEC under the action of GXK at different times (𝑋±𝑠, 𝑛=3).

Groups	MMP
	3 h	6 h	12 h	24 h
Control	1085.21±12.24	992.24±13.32	965.67±12.67	932.43±15.14
Model	712.25±16.31^∗	584.69±19.21^∗	498.17±20.26^∗	389.56±22.36^∗
GXKL	737.79±17.42	673.73±16.91	624.29±17.41	510.32±20.47^#
GXKM	755.22±17.21	736.53±17.69^#	799.43±16.38^#	856.26±15.81^#
GXKH	781.27±16.31	801.25±16.31^#	863.64±14.93^#	915.64±16.83^#

Note: GXK: Guanxinkang; GXKL: Guanxinkang low dose group; GXKM: Guanxinkang medium dose group; GXKH: Guanxinkang high dose group; MMP: mitochondrial membrane potential; *compared with control group, 𝑃<0.05; ^#compared with HCY model group, 𝑃<0.05.